NO933445L - Heterocyklisk-cykliske amin-derivater - Google Patents
Heterocyklisk-cykliske amin-derivaterInfo
- Publication number
- NO933445L NO933445L NO93933445A NO933445A NO933445L NO 933445 L NO933445 L NO 933445L NO 93933445 A NO93933445 A NO 93933445A NO 933445 A NO933445 A NO 933445A NO 933445 L NO933445 L NO 933445L
- Authority
- NO
- Norway
- Prior art keywords
- heterocyclic
- cyclic amine
- amine derivatives
- compounds
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67691891A | 1991-03-28 | 1991-03-28 | |
| PCT/US1992/001605 WO1992017475A1 (en) | 1991-03-28 | 1992-03-09 | Heterocyclic-cyclic amine derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO933445D0 NO933445D0 (no) | 1993-09-27 |
| NO933445L true NO933445L (no) | 1993-09-27 |
| NO304071B1 NO304071B1 (no) | 1998-10-19 |
Family
ID=24716559
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO933445A NO304071B1 (no) | 1991-03-28 | 1993-09-27 | Heterocyklisk-cykliske amin-derivater |
Country Status (29)
| Country | Link |
|---|---|
| EP (1) | EP0646115B1 (no) |
| JP (3) | JP2659107B2 (no) |
| KR (1) | KR0179054B1 (no) |
| CN (1) | CN1044242C (no) |
| AT (1) | ATE231505T1 (no) |
| AU (2) | AU658194B2 (no) |
| BR (1) | BR9205811A (no) |
| CA (2) | CA2195129C (no) |
| CZ (1) | CZ289756B6 (no) |
| DE (1) | DE69232907T2 (no) |
| DK (1) | DK0646115T3 (no) |
| EG (1) | EG20281A (no) |
| ES (1) | ES2188584T3 (no) |
| FI (1) | FI934223A (no) |
| HU (1) | HU225047B1 (no) |
| IE (1) | IE920980A1 (no) |
| IL (3) | IL101327A (no) |
| MX (1) | MX9201419A (no) |
| MY (1) | MY108885A (no) |
| NO (1) | NO304071B1 (no) |
| NZ (3) | NZ242151A (no) |
| PL (3) | PL171914B1 (no) |
| PT (1) | PT100300B (no) |
| RU (1) | RU2119920C1 (no) |
| SG (1) | SG49055A1 (no) |
| UA (1) | UA45944C2 (no) |
| WO (1) | WO1992017475A1 (no) |
| YU (1) | YU31392A (no) |
| ZA (1) | ZA922239B (no) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5750542A (en) * | 1993-09-28 | 1998-05-12 | Pfizer | Benzisoxazole and benzisothizole derivatives as cholinesterase inhibitors |
| EP0602242A4 (en) * | 1991-08-22 | 1994-06-29 | Yoshitomi Pharmaceutical | Benzisoxazole compound and use thereof. |
| EP0535496A1 (en) * | 1991-09-25 | 1993-04-07 | Hoechst-Roussel Pharmaceuticals Incorporated | (1-Indanon-2yl)methylpiperidines, intermediates and a process for their preparation and their use as medicaments |
| CA2149918A1 (en) * | 1992-11-23 | 1994-06-09 | Mark G. Palermo | Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds |
| US5494908A (en) * | 1992-11-23 | 1996-02-27 | Hoechst-Roussel Pharmaceutical Incorporated | Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds |
| GB9305623D0 (en) * | 1993-03-18 | 1993-05-05 | Merck Sharp & Dohme | Therapeutic agents |
| PT788500E (pt) * | 1994-10-26 | 2004-05-31 | Pfizer | Processos e intermediarios para a preparacao de 5,7-dihidro-3-¬2-{1-benziloioeridin-4-il}etil|-6h-pirrolo-¬4,5-f|-1,2-benzisoxazol-6-ona |
| AU4859596A (en) * | 1995-02-15 | 1996-09-04 | Pharmacia & Upjohn Company | Imidazo{1,2-a}pyridines for the treatment of cns and cardiac diseases |
| EP0816362A4 (en) * | 1995-03-22 | 1998-07-08 | Taisho Pharmaceutical Co Ltd | THIAZOLE DERIVATIVES |
| ATE199147T1 (de) * | 1995-06-06 | 2001-02-15 | Aventis Pharma Inc | Benzisoxazol- und indazol- derivate als antipsychotika |
| JPH09124643A (ja) * | 1995-08-14 | 1997-05-13 | Bristol Myers Squibb Co | 抗うつ作用を有する１−アリールアルキル−４−（アルコキシピリジニル）−又は４−（アルコキシピリミジニル）ピペラジン誘導体 |
| US5916902A (en) * | 1995-09-13 | 1999-06-29 | Pfizer Inc. | Processes and intermediates for preparing 5, 7-dihydro-3- 2-(1-benzylpiperidin-4-yl)ethyl-!6H-pyrrolo- 4, 5-F!-1, 2-benzisoxazol-6-one |
| US5998415A (en) * | 1995-11-02 | 1999-12-07 | Merck Sharp & Dohme Ltd. | Bicyclic heteroaryl-alkylene-(homo)piperazinones and thione analogues thereof, their preparation, and their use of as selective agonists of 5-HT1 -like receptors |
| FR2751412B3 (fr) * | 1996-07-17 | 1998-09-25 | Valbiofrance | Methodes de diagnostic in vitro de maladies neurodegeneratives et trousses pour la mise en oeuvre de ces methodes |
| US6013654A (en) * | 1997-08-14 | 2000-01-11 | Pharmacia & Upjohn Company | Imidazo[1,2-A]pyridines for the treatment of CNS and cardiac diseases |
| EP0976404A3 (en) * | 1998-07-30 | 2001-06-27 | Pfizer Products Inc. | A pharmaceutical composition for the prevention and treatment of diseases of cognitive dysfunction in a mammal |
| WO2000018391A1 (fr) | 1998-09-30 | 2000-04-06 | Takeda Chemical Industries, Ltd. | Medicaments qui ameliorent le pouvoir de vidange de la vessie |
| US6951873B1 (en) | 1999-04-27 | 2005-10-04 | Pfizer Inc. | Methods for treating age-related behavioral disorders in companion animals |
| EP1050303A3 (en) * | 1999-04-27 | 2003-01-15 | Pfizer Products Inc. | Methods and compositions for treating age-related behavioral disorders in companion animals |
| EP1048302A3 (en) * | 1999-04-30 | 2002-07-17 | Pfizer Products Inc. | Radiotracers for in vivo study of acetylcholinesterase and Alzheimer's disease |
| GB9914486D0 (en) | 1999-06-21 | 1999-08-18 | Smithkline Beecham Plc | Medicaments |
| GB9917406D0 (en) | 1999-07-23 | 1999-09-22 | Smithkline Beecham Plc | Compounds |
| GB9917408D0 (en) | 1999-07-23 | 1999-09-22 | Smithkline Beecham Plc | Compounds |
| US7091218B1 (en) | 1999-09-01 | 2006-08-15 | Eisai Co., Ltd. | 4-substituted piperidine compound |
| EP1300395B1 (en) | 2000-06-21 | 2009-09-02 | Eisai R&D Management Co., Ltd. | 4-substituted piperidine compound |
| EP1609783A1 (en) * | 2004-06-17 | 2005-12-28 | Neuropharma S.A.U. | Marine compounds with calcium channel blocking properties for Alzheimer's disease treatment |
| DE102005038947A1 (de) * | 2005-05-18 | 2006-11-30 | Grünenthal GmbH | Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln |
| EP1907384A2 (en) * | 2005-06-30 | 2008-04-09 | Prosidion Limited | Gpcr agonists |
| GB0519879D0 (en) | 2005-09-30 | 2005-11-09 | Astrazeneca Ab | Chemical process |
| WO2007126041A1 (ja) | 2006-04-28 | 2007-11-08 | Eisai R & D Management Co., Ltd. | ベンゾイソオキサゾール化合物 |
| EP2164852A2 (en) | 2007-06-01 | 2010-03-24 | Schering Corporation | Gamma secretase modulators |
| WO2009134666A1 (en) | 2008-04-29 | 2009-11-05 | Boehringer Ingelheim International Gmbh | Indazole compounds as ccr1 receptor antagonists |
| JP5411927B2 (ja) | 2008-05-06 | 2014-02-12 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｃｃｒ１アンタゴニストとしてのピラゾール化合物 |
| UA103634C2 (en) | 2008-09-26 | 2013-11-11 | Берингер Ингельхайм Интернациональ Гмбх | Azaindazole compounds as ccr1 receptor antagonists |
| ES2435596T3 (es) * | 2008-12-12 | 2013-12-20 | Actelion Pharmaceuticals Ltd. | Derivados de 5-amino-2-(1-hidroxi-etil)-tetrahidropirano |
| IN2012DN03449A (no) | 2009-10-21 | 2015-10-23 | Boehringer Ingelheim Int | |
| JP5542214B2 (ja) | 2009-10-27 | 2014-07-09 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｃｃｒ１受容体アンタゴニストとしての複素環化合物 |
| CA2789014C (en) | 2010-02-09 | 2019-01-15 | Michela Gallagher | Methods and compositions for improving cognitive function |
| US8871786B2 (en) | 2010-04-30 | 2014-10-28 | Boehringer Ingelheim International Gmbh | Azaindazole amide compounds as CCR1 receptor antagonists |
| EP2655371B1 (en) | 2010-12-23 | 2015-02-25 | Boehringer Ingelheim International GmbH | Pyrazolopiperidine compounds as ccr1 receptor antagonists |
| JP6440625B2 (ja) | 2012-11-14 | 2018-12-19 | ザ・ジョンズ・ホプキンス・ユニバーシティー | 精神分裂病を処置するための方法および組成物 |
| RU2659036C2 (ru) * | 2012-11-21 | 2018-06-27 | Раквалиа Фарма Инк. | Полиморфные формы |
| WO2014144663A1 (en) | 2013-03-15 | 2014-09-18 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
| CA2904767C (en) | 2013-03-15 | 2022-06-21 | Agenebio, Inc. | Methods and compositions for improving cognitive function |
| WO2016191288A1 (en) | 2015-05-22 | 2016-12-01 | Agenebio, Inc. | Extended release pharmaceutical compositions of levetiracetam |
| RU2638155C1 (ru) * | 2016-02-29 | 2017-12-12 | Общество С Ограниченной Ответственностью "Сай Фарма" | Производные бензо[d]изоксазола и их применение |
| CA3228411A1 (en) * | 2021-08-10 | 2023-02-16 | Xiaomin Zhang | Sulfonamide derivative, preparation method therefor and medical use thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3488353A (en) * | 1967-05-29 | 1970-01-06 | Sterling Drug Inc | New 1-((2-azaindolyl)-lower-alkyl) 4-substituted-piperazines |
| JPS51136666A (en) * | 1975-05-19 | 1976-11-26 | Dainippon Pharmaceut Co Ltd | Process for preparing 3-aminoalkyl-1,2-benzisoxazole derivatives. |
| US4396770A (en) * | 1982-04-09 | 1983-08-02 | Hoechst-Roussel Pharmaceuticals Inc. | 1-[3-(6-Fluoro-1,2-benzisoxazol-3-yl)propyl]-4-hydroxy-4-phenylpiperidines |
| IL66866A (en) * | 1982-04-09 | 1987-08-31 | Hoechst Roussel Pharma | 1-(3-(6-fluoro-1,2-benzisoxazol-3-yl)propyl)-4-(substituted)-piperazines and-piperidines,a process for the preparation thereof,and pharmaceutical compositions containing them |
| US4489075A (en) * | 1982-05-15 | 1984-12-18 | Pfizer Inc. | Cyclic sulfonamidoalkyl substituted 4-piperidinoquinazoline cardiac stimulants |
| PH22302A (en) * | 1985-02-11 | 1988-07-22 | Fujisawa Pharmaceutical Co | Piperidine compounds |
| DK623586A (da) * | 1985-12-27 | 1987-06-28 | Eisai Co Ltd | Piperidinderivater eller salte deraf og farmaceutiske kompositioner indeholdende forbindelserne |
| JPS63234065A (ja) * | 1987-03-23 | 1988-09-29 | Mitsubishi Rayon Co Ltd | 包接能を有する高分子組成物 |
| JPH0657707B2 (ja) * | 1987-05-25 | 1994-08-03 | 吉富製薬株式会社 | ピペリジン化合物 |
| FI95572C (fi) * | 1987-06-22 | 1996-02-26 | Eisai Co Ltd | Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi |
| US4980365A (en) * | 1987-07-13 | 1990-12-25 | Hoechst-Roussel Pharmaceuticals Inc. | N-substituted-5,6-dimethoxy-1,2-benzisoxazole-3-propanamine and related compounds as analgesic and hypotensive agents |
| ATE87918T1 (de) * | 1988-02-19 | 1993-04-15 | Lilly Co Eli | Tetrazolverbindungen als antagonisten der excitatorischen aminosaeurerezeptoren. |
| JPH0283375A (ja) * | 1988-09-21 | 1990-03-23 | Dainippon Pharmaceut Co Ltd | ２−置換ピペラジニル−２−（１，２−ベンズイソキサゾール−３−イル）酢酸誘導体 |
| FR2654104B1 (fr) * | 1989-11-07 | 1992-01-03 | Adir | Nouveaux derives du 1,2-benzisoxazole, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. |
| JP3176063B2 (ja) * | 1991-04-17 | 2001-06-11 | ファルマシア・アンド・アップジョン・カンパニー | 新規中枢神経作用性置換フェニルアザシクロアルカン類 |
-
1992
- 1992-03-09 ES ES92921695T patent/ES2188584T3/es not_active Expired - Lifetime
- 1992-03-09 CA CA002195129A patent/CA2195129C/en not_active Expired - Fee Related
- 1992-03-09 DK DK92921695T patent/DK0646115T3/da active
- 1992-03-09 CA CA002107105A patent/CA2107105C/en not_active Expired - Fee Related
- 1992-03-09 WO PCT/US1992/001605 patent/WO1992017475A1/en active IP Right Grant
- 1992-03-09 JP JP4510182A patent/JP2659107B2/ja not_active Expired - Fee Related
- 1992-03-09 DE DE69232907T patent/DE69232907T2/de not_active Expired - Fee Related
- 1992-03-09 CZ CS19923958A patent/CZ289756B6/cs not_active IP Right Cessation
- 1992-03-09 UA UA93004393A patent/UA45944C2/uk unknown
- 1992-03-09 AU AU18782/92A patent/AU658194B2/en not_active Ceased
- 1992-03-09 HU HU9302733A patent/HU225047B1/hu not_active IP Right Cessation
- 1992-03-09 PL PL92313812A patent/PL171914B1/pl not_active IP Right Cessation
- 1992-03-09 BR BR9205811A patent/BR9205811A/pt not_active Application Discontinuation
- 1992-03-09 RU RU93055137A patent/RU2119920C1/ru not_active IP Right Cessation
- 1992-03-09 AT AT92921695T patent/ATE231505T1/de not_active IP Right Cessation
- 1992-03-09 PL PL92300711A patent/PL170567B1/pl not_active IP Right Cessation
- 1992-03-09 PL PL92313811A patent/PL171915B1/pl not_active IP Right Cessation
- 1992-03-09 EP EP92921695A patent/EP0646115B1/en not_active Expired - Lifetime
- 1992-03-09 SG SG1996005572A patent/SG49055A1/en unknown
- 1992-03-22 IL IL101327A patent/IL101327A/en active IP Right Grant
- 1992-03-22 IL IL11612292A patent/IL116122A/en active IP Right Grant
- 1992-03-22 IL IL11612295A patent/IL116122A0/xx unknown
- 1992-03-26 EG EG15592A patent/EG20281A/xx active
- 1992-03-26 PT PT100300A patent/PT100300B/pt not_active IP Right Cessation
- 1992-03-27 NZ NZ242151A patent/NZ242151A/en not_active IP Right Cessation
- 1992-03-27 IE IE098092A patent/IE920980A1/en not_active IP Right Cessation
- 1992-03-27 ZA ZA922239A patent/ZA922239B/xx unknown
- 1992-03-27 NZ NZ250987A patent/NZ250987A/en not_active IP Right Cessation
- 1992-03-27 MY MYPI92000531A patent/MY108885A/en unknown
- 1992-03-27 YU YU31392A patent/YU31392A/sh unknown
- 1992-03-27 CN CN92102178A patent/CN1044242C/zh not_active Expired - Fee Related
- 1992-03-27 NZ NZ248946A patent/NZ248946A/en not_active IP Right Cessation
- 1992-03-30 MX MX9201419A patent/MX9201419A/es not_active IP Right Cessation
-
1993
- 1993-09-27 FI FI934223A patent/FI934223A/fi not_active Application Discontinuation
- 1993-09-27 NO NO933445A patent/NO304071B1/no unknown
- 1993-09-27 KR KR1019930702929A patent/KR0179054B1/ko not_active IP Right Cessation
-
1995
- 1995-06-20 AU AU21788/95A patent/AU674477B2/en not_active Ceased
-
1997
- 1997-03-06 JP JP9052097A patent/JP3051076B2/ja not_active Expired - Fee Related
-
1999
- 1999-12-24 JP JP11368302A patent/JP2000154185A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO304071B1 (no) | Heterocyklisk-cykliske amin-derivater | |
| DK348189A (da) | Kondenserede heterocyckliske forbindelser | |
| DK0468012T3 (da) | 17beta-substituerede 4-aza-5alfa-androstan-3-on-derivater og fremgangsmåde til fremstilling deraf | |
| DK0563345T3 (da) | Nye 4-arylpiperaziner og 4-arylpiperidiner | |
| NO924598L (no) | Fremstilling av substituerte piperidiner | |
| ATE63309T1 (de) | 2,3-dihydro-2-oxo-3-benzofuranylessigs|urederivate und diese enthaltende arzneimittel. | |
| DK1105388T3 (da) | N-substituerede azabicycloheptan-derivater, fremstilling og anvendelse heraf |